Science + Tech

December 04, 2020 - Physicians Committe for Responsible Medicine

USA: FDA Launches Program to Approve Human Biology-Based Methods for Use in Drug Development

This week, the U.S. Food and Drug Administration (FDA) launched Innovative Science and Technology Approaches for New Drugs (ISTAND), a pilot program that will help reduce and replace animal testing as part of drug development.

The Physicians Committee for Responsible Medicine has worked toward this goal for several years by meeting with the FDA and Congress and providing expert input, hosting Congressional briefings, and leading drug development stakeholders in advocating for a pathway for the approval of nonanimal, human-biology based drug testing methods.

Continue Reading at:

Physicians Committe for Responsible Medicine